US 12,239,451 B2
Oral food challenge meal formulations
Clare Mills, Altrincham (GB); Anuradha Balasundaram, Sale (GB); Carol Ann Costello, Chorlton (GB); Ivona Baricevic-Jones, Stockport (GB); and Martin Wickham, Deeside (GB)
Assigned to Reacta Biotech Limited, Deeside (GB)
Filed by Reacta Biotech Limited, Deeside (GB)
Filed on Aug. 12, 2022, as Appl. No. 17/887,246.
Application 17/887,246 is a continuation of application No. 16/347,753, granted, now 11,439,342, previously published as PCT/GB2016/053829, filed on Dec. 5, 2016.
Prior Publication US 2022/0386938 A1, Dec. 8, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 49/00 (2006.01); A23L 25/00 (2016.01); A23L 29/212 (2016.01); A23L 33/115 (2016.01); A61B 5/00 (2006.01)
CPC A61B 5/411 (2013.01) [A23L 25/30 (2016.08); A23L 29/212 (2016.08); A23L 33/115 (2016.08)] 20 Claims
 
1. A kit comprising:
a non-placebo challenge meal formulation comprising allergen, wherein the allergen is present in the non-placebo challenge meal formulation in an amount of more than about 10% w/w and less than about 25% w/w; and
a placebo challenge meal formulation comprising no food allergen, wherein the placebo challenge meal formulation comprises an additive present in an amount of from about 0.05% w/w to less than 0.9% w/w of the placebo challenge meal formulation, wherein the additive is selected from the group consisting of: maltodextrin, dextrin, cyclodextrin and combinations thereof.